TherapeuticsMD (TXMD) EBT (2010 - 2026)

TherapeuticsMD has reported EBT for 17 years, with the latest figure at $103000.0 in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 115.42% year-over-year to $103000.0; the trailing twelve-month figure through Mar 2026 stood at $118000.0 (up 105.36% YoY), and the FY2025 full-year result was -$653000.0, up 72.13% from the prior year.
• EBT for Q1 2026 stood at $103000.0, up from -$580000.0 in the prior quarter.
• The five-year high for EBT was $48.5 million in Q4 2022, with the low at -$17.9 million in Q1 2022.
• Historically, EBT has averaged -$562411.8 across 5 years, with a median of -$809000.0 in 2024.
• The largest YoY upside for EBT was 151.9% in 2025 against a maximum downside of 798.8% in 2025.
• TherapeuticsMD's EBT stood at $48.5 million in 2022, then plunged by 103.27% to -$1.6 million in 2023, then surged by 105.24% to $83000.0 in 2024, then slumped by 798.8% to -$580000.0 in 2025, then surged by 117.76% to $103000.0 in 2026.
• The last three EBT figures came in at $103000.0 (Q1 2026), -$580000.0 (Q4 2025), and $50000.0 (Q3 2025), per Business Quant data.